198 related articles for article (PubMed ID: 22327101)
21. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
[TBL] [Abstract][Full Text] [Related]
22. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
Sharma KL; Misra S; Kumar A; Mittal B
Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
[TBL] [Abstract][Full Text] [Related]
23. Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels.
Marson BP; Lacchini R; Belo V; Mattos SG; da Costa BP; Poli-de-Figueiredo CE; Tanus-Santos JE
Clin Chim Acta; 2012 Dec; 414():46-51. PubMed ID: 23010359
[TBL] [Abstract][Full Text] [Related]
24. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.
Luizon MR; Belo VA; Palei AC; Amaral LM; Lacchini R; Sandrim VC; Duarte G; Cavalli RC; Tanus-Santos JE
Hypertens Res; 2015 May; 38(5):361-6. PubMed ID: 25716650
[TBL] [Abstract][Full Text] [Related]
25. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury.
Jacob-Ferreira AL; Passos CJ; Gerlach RF; Barbosa F; Tanus-Santos JE
Sci Total Environ; 2010 Sep; 408(19):4085-92. PubMed ID: 20554312
[TBL] [Abstract][Full Text] [Related]
26. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Luizon MR; Palei ACT; Belo VA; Amaral LM; Lacchini R; Duarte G; Cavalli RC; Sandrim VC; Tanus-Santos JE
Pharmacogenomics J; 2017 Oct; 17(5):427-434. PubMed ID: 27168100
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 and 2 as potential biomarkers for gestational hypertension.
Ab Hamid J; Mohtarrudin N; Osman M; Andi Asri AA; Wan Hassan WH; Aziz R
Singapore Med J; 2012 Oct; 53(10):681-3. PubMed ID: 23112021
[TBL] [Abstract][Full Text] [Related]
28. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.
Demacq C; Vasconcellos VB; Marcaccini AM; Gerlach RF; Machado AA; Tanus-Santos JE
Pharmacogenomics J; 2009 Aug; 9(4):265-73. PubMed ID: 19381161
[TBL] [Abstract][Full Text] [Related]
29. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
[TBL] [Abstract][Full Text] [Related]
30. Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy.
Luizon MR; Sandrim VC; Palei AC; Lacchini R; Cavalli RC; Duarte G; Tanus-Santos JE
Hypertens Res; 2012 Sep; 35(9):917-21. PubMed ID: 22573202
[TBL] [Abstract][Full Text] [Related]
31. Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy.
Aggarwal PK; Jain V; Jha V
Hypertens Res; 2010 May; 33(5):473-7. PubMed ID: 20186148
[TBL] [Abstract][Full Text] [Related]
32. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension.
Sandrim VC; Palei AC; Luizon MR; Izidoro-Toledo TC; Cavalli RC; Tanus-Santos JE
Pharmacogenomics J; 2010 Feb; 10(1):40-5. PubMed ID: 19704415
[TBL] [Abstract][Full Text] [Related]
33. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia.
Sandrim VC; Palei AC; Sertorio JT; Cavalli RC; Duarte G; Tanus-Santos JE
Mol Hum Reprod; 2010 Jul; 16(7):506-10. PubMed ID: 20457799
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
[TBL] [Abstract][Full Text] [Related]
36. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
Wei JC; Lee HS; Chen WC; Shiu LJ; Yang SF; Wong RH
Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
[TBL] [Abstract][Full Text] [Related]
38. eNOS tag SNP haplotypes in hypertensive disorders of pregnancy.
Muniz L; Luizon MR; Palei AC; Lacchini R; Duarte G; Cavalli RC; Tanus-Santos JE; Sandrim VC
DNA Cell Biol; 2012 Dec; 31(12):1665-70. PubMed ID: 23062210
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls.
Stojanovic N; Lewandowski K; Salata I; Bienkiewicz M; Tuck S; Prelevic G; Press M
Gynecol Endocrinol; 2010 Mar; 26(3):201-7. PubMed ID: 19526397
[TBL] [Abstract][Full Text] [Related]
40. Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine.
Martins-Oliveira A; Gonçalves FM; Speciali JG; Fontana V; Izidoro-Toledo TC; Belo VA; Dach F; Tanus-Santos JE
J Neuroimmunol; 2012 Nov; 252(1-2):89-94. PubMed ID: 22907074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
